A dose-intensive regimen of 5-fluorouracil for the treatment of metastatic colorectal carcinoma
Open Access
- 15 January 1991
- Vol. 67 (2) , 367-371
- https://doi.org/10.1002/1097-0142(19910115)67:2<367::aid-cncr2820670209>3.0.co;2-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer.Journal of Clinical Oncology, 1990
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.Journal of Clinical Oncology, 1989
- High-performance liquid chromatographic analysis of fluoropyrimidine nucleosides and fluorouracil in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Phase I and pharmacologic study of 72-hour infused 5-fluorouracil in manAmerican Journal of Clinical Oncology, 1985
- 5-Fluorouracil (FUra)Pharmacology & Therapeutics, 1984
- Effect of allopurinol on the toxicity of high-dose 5-fluorouracil administered by intermittent bolus injectionCancer, 1983
- A phase III study comparing the clinical utility of four regimens of 5-Fluorouracil.A preliminary reportCancer, 1977